Literature DB >> 14531265

[Heparin resistance during cardiopulmonary bypass].

Ryoko Maeda1, Hirokazu Fukuda, Yasushi Nakaigawa, Masahiro Hiruta, Yoshihiro Hirabayashi, Norimasa Seo.   

Abstract

A 74-year-old man was scheduled for coronary artery bypass graft surgery with cardiopulmonary bypass. After intravenous heparin (200 U.kg-1), the activated clotting time (ACT) increased from 124 to 436 sec. However, it decreased to 128 sec immediately after cardiopulmonary bypass. The bypass was discontinued because the addition of heparin (200 U.kg-1) proved heparin resistance. The coronary artery bypass procedure was completed uneventfully without cardiopulmonary bypass. Several recent articles have reported that heparin resistance was corrected with antithrombin III concentrates, fresh frozen plasma, or argatroban. In this case, these drugs could not be used because the mechanism of heparin resistance remains uncertain. Thus, the off-pump technique is useful for unknown heparin resistance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14531265

Source DB:  PubMed          Journal:  Masui        ISSN: 0021-4892


  1 in total

1.  Strategy for Cardiovascular Surgery in Patients with Antithrombin III Deficiency.

Authors:  Yoshiyuki Nishimura; Yasushi Takagi
Journal:  Ann Thorac Cardiovasc Surg       Date:  2018-04-20       Impact factor: 1.520

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.